Reliance Pharma Fund(G)

153.44 1.76 (1.16%) NAV as on 21-Nov-18
52-Week High ( ) 165.89 (07-Sep-18)
52-Week Low ( ) 132.05 (23-Mar-18)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 2752.02
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return14.9411.901.4920.77
Category Avg0.85-6.02-5.0710.70
Category Best6.111.76-0.8320.87
Category Worst-4.12-13.46-7.57-6.29
SENSEX1.695.1410.81-
BSE HC13.372.60-4.38-
NIFTY0.792.6510.50-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Divi's Laboratories LimitedDomestic Equities10.64
Dr. Reddy's Laboratories LimitedDomestic Equities10.16
Aurobindo Pharma LimitedDomestic Equities9.49
Sun Pharmaceutical Industries LimitedDomestic Equities9.28
Cipla LimitedDomestic Equities6.86
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 21/11/2018 As on 21/11/2018

10600.05 (-0.53) 35199.80 (-0.77)

TOP GAINERS

Company Price Change Gain (%)
MVL0.250.0525.00
Shekhawati Poly-Yarn0.300.0520.00

TOP LOSERS

Company Price Change Loss (%)
Uttam Value Steels0.10-0.05-33.33
Raj Rayon Industries0.15-0.05-25.00

Portfolio Comparison

MUTUAL FUND ACTIVITY